case_images: PMC11320671_01
case_images: PMC11320671_02
case_images: Evolution of FEV1 (%) and KCO (%) in a patient with symptomatic COPD and severe AATD not on augmentation (case 2).. AATD, Alpha-1 antitrypsin deficiency; COVID-19, coronavirus disease 2019; FEV1, forced expiratory volume in one second; KCO, carbon monoxide transfer coefficient.
case_images: 10.1177_17534666241271917-fig1.jpg
case_images: PMC11320671_02_10.1177_17534666241271917-fig1.jpg
case_images: fig1-17534666241271917
case_images: FEV1 of 1.45 L (56%), FEV1/FVC of 0.42 and KCO of 52%. Figure 1 shows the evolution of the patient's lung function values.
case_images: PMC11320671_03
case_images: PMC11320671_04
case_images: PMC11320671_05
case_images: Evolution of FEV1 (%) and KCO (%) in a patient with bronchiectasis and severe AATD (case 5).. AATD, Alpha-1 antitrypsin deficiency; COVID-19, coronavirus disease 2019; FEV1, forced expiratory volume in one second; KCO, carbon monoxide transfer coefficient
case_images: 10.1177_17534666241271917-fig2.jpg
case_images: PMC11320671_05_10.1177_17534666241271917-fig2.jpg
case_images: fig2-17534666241271917
case_images: The patient has been followed annually in our centre since 2016 and the evolution of lung function is shown in Figure 2.